Clear indication definition

Clear indication means that the capacity labelling shall be expressed in terms of a unit (mAh) and that other numerical markings on the battery must not be such that the customer is likely to be misled into thinking that they represent the capacity labelling.
Sample 1Sample 2Sample 3

Examples of Clear indication in a sentence

  • Clear indication thereof must be stated on the schedules attached.

  • Clear indication of the position of the handle shall be incorporated.

  • Clear indication of what is being guaranteed and what remedial action will be taken under guarantee.

  • Clear indication of whether the results are entirely satisfactory and whether retesting or re-inspection is required.

  • Clear indication of any submittal item which may include a deviation from the Contract Documents.

  • Clear indication must exist that the faculty and staff were responsible for preparing, revising, and editing any documents required in the accreditation process.

  • Clear indication, in bold type, that the product contains medical cannabis.

  • Clear indication of the contact details of the respective pharmacovigilance depart- ment is required.

  • Clear indication thereof must be stated on the schedules attached.The Department is under no obligation to pay suppliers in part for work done if the supplier can no longer for fulfil their obligation.

  • Clear indication thereof must be stated on the schedulesattached.

Related to Clear indication

  • Exempt compound means the same as defined in Rule 2.

  • Phase 3 Clinical Trial means a pivotal clinical trial in humans performed to gain evidence with statistical significance of the efficacy of a product in a target population, and to obtain expanded evidence of safety for such product that is needed to evaluate the overall benefit-risk relationship of such product, to form the basis for approval of an NDA and to provide an adequate basis for physician labeling, as described in 21 C.F.R. § 312.21(c) or the corresponding regulation in jurisdictions other than the United States.

  • Diagnostic Product means a diagnostic product, containing one or more Program Materials, for use in the in vivo detection of any disease or condition in humans.

  • geographical indication , in relation to goods, means an indication which identifies such goods as agricultural goods, natural goods or manufactured goods as originating, or manufactured in the territory of a country, or a region or locality in that territory, where a given quality, reputation or other characteristic of such goods is essentially attributable to its geographical origin and in case where such goods are manufactured goods one of the activities of either the production or of processing or preparation of the goods concerned takes place in such territory, region or locality, as the case may be.

  • Phase 4 Clinical Trial means a Clinical Study in any country which is conducted after Regulatory Approval of a product has been obtained from an appropriate Regulatory Authority, consisting of trials conducted voluntarily for enhancing marketing or scientific knowledge of an approved indication and trials conducted due to request or requirement of a Regulatory Authority.

  • Clinical Trial means a Phase I Clinical Trial, Phase II Clinical Trial or Phase III Clinical Trial, or any post-approval human clinical trial, as applicable.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Phase 2 Clinical Trial means a human clinical trial, for which the primary endpoints include a determination of dose ranges or an indication of efficacy in patients being studied as described in 21 C.F.R. §312.21(b), or an equivalent clinical trial in a country in the Territory other than the United States.

  • Licensed Product means a product, method or service in the Licensed Field of Use, the making, having made, using, importing or selling of which, absent this license, infringes, induces infringement, or contributes to infringement of a Licensed Patent.

  • Phase 1 Clinical Trial means a human clinical trial of a Licensed Product that would satisfy the requirements of 21 C.F.R. 312.21(a) or corresponding foreign regulations.

  • Phase IV Clinical Trial means a product support clinical trial of a Product commenced after receipt of Regulatory Approval in the country where such trial is conducted. A Phase IV Clinical Trial may include epidemiological studies, modeling and pharmacoeconomic studies, and investigator-sponsored clinical trials studying Product that are approved by BMS and that otherwise fit the foregoing definition.